Developing a Seamless Transition Strategy from GLP to GMP Labs in Pharma R&D: Enhancing Product Quality and Regulatory Compliance
Time: 10:50AM - 11:50AM
Date: 19-March-2024-Block-2
Synopsis
Speakers
Daniel O’Connell Associate Director, Facilities Operations - Alnylam Pharmaceuticals
« Back
